FDA Approves First COVID-19 Treatment for Young Children
The press release was published on the U.S. Food and Drug Administration website: On Apr. 26, 2022, the U.S. Food
Tag: Covid-19
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of
CycloLab awarded by 2021 Innovation Grand Prize
The Hungarian Association of Innovation awarded CycloLab with this prestigious prize due to its meaningful and very profitable innovation concerning
Nature News on Covid drugs: overview and new trends
Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more
Comparative evaluation of HPBCD-adjuvanted booster vaccine
Background: Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are
Scientists are racing to develop more COVID antivirals
Nature News evaluated antiviral drugs developed for the treatment of Covid-19. Clinical-trial data showed that molnupiravir, developed by the pharmaceutical
Spike Ferritin Nanoparticle Covid-19 vaccine
The US Army has recently developed a SARS-CoV-2 sub-unit vaccine based on a ferritin nanoparticle platform that displays a pre-fusion
Alpha-cyclodextrin and Hydroxytyrosol against SARS-CoV-2 infection
In the last year, the Cyclodextrin News reported on an oral spray containing alpha-cyclodextrin and hydroxytyrosol developed by Italian researchers
HPBCD solubilized pazopanib against lung injuries due to coronavirus infection
Professor Wu Dianquing at Yale university has discovered that a widely used anticancer drug, pazopanib might be suitable for treating
Molecular interactions in remdesivir-cyclodextrin systems
In a recently published study intermolecular interactions of remdesivir and various cyclodextrin derivatives were characterized by extensive NMR spectroscopy. The